33.79
+3.97
+(13.29%)
At close: April 17 at 4:00:01 PM EDT
33.90
+0.11
+(0.33%)
After hours: April 17 at 6:19:29 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
483,110
87,948
115,128
292,747
Total Liabilities Net Minority Interest
37,660
18,279
39,022
41,935
Total Equity Gross Minority Interest
445,450
69,669
76,106
250,812
Total Capitalization
445,450
69,669
76,106
250,812
Common Stock Equity
445,450
69,669
76,106
250,812
Capital Lease Obligations
1,369
2,495
3,500
4,311
Net Tangible Assets
445,450
69,669
76,106
250,812
Working Capital
366,822
69,131
76,495
248,975
Invested Capital
445,450
69,669
76,106
250,812
Tangible Book Value
445,450
69,669
76,106
250,812
Total Debt
1,369
2,495
3,500
4,311
Share Issued
19,400
8,791.88
3,292.16
3,020.03
Ordinary Shares Number
19,400
8,791.88
3,292.16
3,020.03
12/31/2021 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRUS Merus N.V.
43.06
+2.73%
VRDN Viridian Therapeutics, Inc.
13.13
+3.79%
XENE Xenon Pharmaceuticals Inc.
35.11
+3.94%
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
SRRK Scholar Rock Holding Corporation
30.75
+3.33%
PTGX Protagonist Therapeutics, Inc.
46.28
+1.05%
STOK Stoke Therapeutics, Inc.
7.69
+1.72%
DYN Dyne Therapeutics, Inc.
8.17
+4.34%
MLYS Mineralys Therapeutics, Inc.
13.35
-1.11%
SLNO Soleno Therapeutics, Inc.
69.98
+0.07%